George Coukos

Biography
Dr. George Coukos pioneering work presently focuses on developing precision immunotherapy in cancer treatment, particularly in T cell therapies. Notably, he's been instrumental in developing personalized immunotherapies, including an autologous dendritic cell vaccine and adoptive T cell therapy with vaccine primed autologous T cells for ovarian cancer treatment. Dr. Coukos's research has unveiled the spontaneous antitumor response in ovarian cancer, expanding its application beyond ovarian to other solid tumors. He also elucidated critical mechanisms governing the interplay between tumors and the immune system, including the role of the tumor vasculature in erecting a barrier to T cell trafficking in tumors. Dr. Coukos is leveraging advanced technologies like high throughput sequencing to tailor immunotherapies based on molecular and genetic specifics of the tumor cells and the tumor microenvironment. His research pursuits of innovative therapies have set new standards in cancer immunotherapy, including the recent development of rational engineering of superior effector T cell states for adoptive therapy.